February 10, 2015

Rheonix Receives $1.5 Million Grant from the National Institute of Dental & Craniofacial Research to Complete Development of a Rapid Point-of-Care Test for HIV/AIDS

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research (SBIR) Phase II grant, under Award Number R44DE024456, from the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH). The grant will allow Rheonix to complete the development of a fully automated self-screening and confirming assay that can simultaneously detect HIV/AIDS antibodies and viral… Read More »